Last reviewed · How we verify
continuation of oxytocin administration
Oxytocin is a peptide hormone that binds to oxytocin receptors to stimulate uterine contractions and promote milk letdown during labor and postpartum hemorrhage management.
Oxytocin is a peptide hormone that binds to oxytocin receptors to stimulate uterine contractions and promote milk letdown during labor and postpartum hemorrhage management. Used for Induction or augmentation of labor, Prevention and treatment of postpartum hemorrhage, Management of incomplete or inevitable abortion.
At a glance
| Generic name | continuation of oxytocin administration |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Drug class | Peptide hormone / Oxytocin receptor agonist |
| Target | Oxytocin receptor (OXTR) |
| Modality | Small molecule |
| Therapeutic area | Obstetrics / Gynecology |
| Phase | FDA-approved |
Mechanism of action
Oxytocin acts as an agonist at oxytocin receptors located on uterine smooth muscle and mammary gland myoepithelial cells. Upon receptor binding, it triggers calcium influx and increases intracellular calcium concentration, leading to sustained uterine contractions during labor and the postpartum period. It also facilitates milk ejection by contracting mammary tissue during lactation.
Approved indications
- Induction or augmentation of labor
- Prevention and treatment of postpartum hemorrhage
- Management of incomplete or inevitable abortion
Common side effects
- Uterine hyperstimulation
- Nausea and vomiting
- Headache
- Hypertension
- Water intoxication (with prolonged high-dose infusion)
- Fetal bradycardia
Key clinical trials
- Reducing Neonatal Morbidity by Discontinuing Oxytocin During the Active Phase of 1st Stage of Labor (PHASE4)
- The Influence of Oxytocin on Intrapartum Fetal Well-being and Delivery Outcomes in Patients Receiving Epidural Analgesia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |